Literature DB >> 26579577

Kynuramines induce overexpression of heat shock proteins in pancreatic cancer cells via 5-hydroxytryptamine and MT1/MT2 receptors.

A Leja-Szpak1, P Pierzchalski2, M Goralska2, K Nawrot-Porabka2, J Bonior2, P Link-Lenczowski2, M Jastrzebska2, J Jaworek2.   

Abstract

Kynuramines, metabolites of melatonin and L-tryptophan, are synthesized endogenously by oxygenases or in spontaneous reaction by an interaction with free radicals. We have reported previously that melatonin stimulates expression and phosphorylation of heat shock protein (HSP) 27, as well as production of HSP70 and HSP90αβ in pancreatic carcinoma cells (PANC-1). Based on those results, we hypothesized that above processes could have been involved in the interruption of intrinsic proapoptotic pathway. Herein, we report that incubation of PANC-1 cells with N(1)-acetyl-N(2)-formyl-5-methoxykynuramine (AFMK) or with L-kynurenine (L-KYN) lead to the overexpression of heat shock protein synthesis and these effects are partially reversed by 5-HT3 or MT1/MT2 receptor antagonists. PANC-1 cells in culture were treated with AFMK or L-KYN, with non selective MT1/MT2 receptor antagonist (luzindole), with 5-HT2 and 5-HT3 receptor antagonists (ketanserin and MDL72222), or combination of these substances. Both AFMK and L-KYN significantly decreased cytoplasmic HSP27 and this effect was presumably due to increased of its phosphorylation and consequent nuclear translocation, confirmed by immunoprecipitation of phosphorylated form of HSP27. These changes were accompanied by marked augmentation of HSP70 and HSP90αβ in the cytosolic fraction. Pretreatment of cell cultures with luzindole or MDL72222 followed by the addition of AFMK or L-KYN reversed the stimulatory effects of these substances on HSP expression in PANC-1 cells, whereas ketanserin failed to influence mentioned above phenomenon. We conclude that activation of HSPs in pancreatic carcinoma cells seems to be dependent on an interaction of AFMK or L-KYN with MT1/MT2 or/and 5-HT3 receptors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26579577

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  9 in total

1.  Evaluation of melatonin and AFMK levels in women with breast cancer.

Authors:  Tialfi Bergamin de Castro; Newton Antônio Bordin-Junior; Eduardo Alves de Almeida; Debora Aparecida Pires de Campos Zuccari
Journal:  Endocrine       Date:  2018-05-24       Impact factor: 3.633

2.  A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women.

Authors:  Li Jiao; Suman Maity; Cristian Coarfa; Kimal Rajapakshe; Liang Chen; Feng Jin; Vasanta Putluri; Lesley F Tinker; Qianxing Mo; Fengju Chen; Subrata Sen; Haleh Sangi-Hyghpeykar; Hashem B El-Serag; Nagireddy Putluri
Journal:  Cancer Prev Res (Phila)       Date:  2019-02-05

3.  1-Mesityl-3-(3-Sulfonatopropyl) Imidazolium Protects Against Oxidative Stress and Delays Proteotoxicity in C. elegans.

Authors:  Natalia Andersen; Tania Veuthey; María Gabriela Blanco; Gustavo Fabian Silbestri; Diego Rayes; María José De Rosa
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

Review 4.  Effects of Melatonin and Its Analogues on Pancreatic Inflammation, Enzyme Secretion, and Tumorigenesis.

Authors:  Jolanta Jaworek; Anna Leja-Szpak; Katarzyna Nawrot-Porąbka; Joanna Szklarczyk; Michalina Kot; Piotr Pierzchalski; Marta Góralska; Piotr Ceranowicz; Zygmunt Warzecha; Artur Dembinski; Joanna Bonior
Journal:  Int J Mol Sci       Date:  2017-05-08       Impact factor: 5.923

Review 5.  Effect of Endotoxemia in Suckling Rats on Pancreatic Integrity and Exocrine Function in Adults: A Review Report.

Authors:  Jolanta Jaworek; Barbara Tudek; Paweł Kowalczyk; Michalina Kot; Joanna Szklarczyk; Anna Leja-Szpak; Piotr Pierzchalski; Joanna Bonior; Artur Dembiński; Piotr Ceranowicz; Zygmunt Warzecha; Katarzyna Nawrot-Porąbka; Krzysztof Gil
Journal:  Gastroenterol Res Pract       Date:  2018-01-14       Impact factor: 2.260

Review 6.  Taxon- and Site-Specific Melatonin Catabolism.

Authors:  Rüdiger Hardeland
Journal:  Molecules       Date:  2017-11-21       Impact factor: 4.411

7.  Melatonin Improves the Quality of Inferior Bovine Oocytes and Promoted Their Subsequent IVF Embryo Development: Mechanisms and Results.

Authors:  Minghui Yang; Jingli Tao; Menglong Chai; Hao Wu; Jing Wang; Guangdong Li; Changjiu He; Lu Xie; Pengyun Ji; Yunping Dai; Liguo Yang; Guoshi Liu
Journal:  Molecules       Date:  2017-11-27       Impact factor: 4.411

8.  In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile.

Authors:  Shuhei Suzuki; Masahiro Yamamoto; Keita Togashi; Tomomi Sanomachi; Asuka Sugai; Shizuka Seino; Takashi Yoshioka; Chifumi Kitanaka; Masashi Okada
Journal:  Oncotarget       Date:  2019-05-28

9.  Melatonin receptor agonist protects against acute lung injury induced by ventilator through up-regulation of IL-10 production.

Authors:  Geng-Chin Wu; Chung-Kan Peng; Wen-I Liao; Hsin-Ping Pao; Kun-Lun Huang; Shi-Jye Chu
Journal:  Respir Res       Date:  2020-03-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.